Pharmanovia Collaborates with Lindis Biotech to Commercialize Catumaxomab for Treating Malignant Ascites
Shots: Pharmanovia has entered into a new licensing agreement with Lindis Biotech...
Bayer Join Forces with Cytokinetics to Develop and Commercialize Aficamten in Japan
Shots: Bayer and Cytokinetics have partnered to develop and commercialize aficamte...
Ratio Therapeutics Partners with Novartis to Advance SSTR2-Targeting Radiotherapeutic Candidate for Cancer
Shots: Ratio Therapeutics has entered into an exclusive worldwide licensing and co...
Merck Join Forces with LaNova Medicines to Advance LM-299 for Advanced Solid Tumors
Shots: Merck and LaNova Medicines have collaborated to develop the latter’s...
Nippon Shinyaku Collaborates with Atsena Therapeutics to Commercialize ATSN-101 Across the US and Japan
Shots: Nippon Shinyaku has signed an exclusive licensing agreement with Atsena to...
Schrödinger Enters into a Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis
Shots: Schrödinger & Novartis have signed a research collaboration &...
